JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FONR
6101
DELISTED
Fonar
FONR
| $12.4K | ﹤0.01% |
632
+64
| +11% | +$1.07K |
2023 Q2
2 quarters
|
|
6102
iShares US Insurance ETF
IAK
$426M
| $12.3K | ﹤0.01% |
123
+18
| +17% | +$1.73K |
2023 Q3
1 quarter
|
|
|
SUNW
6103
DELISTED
Sunworks, Inc.
SUNW
| $12.3K | ﹤0.01% |
52,328
+52,066
| +19,873% | +$17.7K |
2023 Q2
2 quarters
|
|
6104
Rani Therapeutics
RANI
$91.8M
| $12.3K | ﹤0.01% |
3,698
-741
| -17% | -$1.71K |
2021 Q4
8 quarters
|
|
|
CSAN
6105
DELISTED
Cosan
CSAN
| $12.1K | ﹤0.01% |
774
| – | – |
2021 Q1
11 quarters
|
|
|
GATEW
6106
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
| – | – |
0
| – | – |
2023 Q4
0 quarters
|
|
6107
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$299M
| $12.1K | ﹤0.01% |
600
| – | – |
2023 Q3
1 quarter
|
|
|
TRVG
6108
trivago
TRVG
$356M
| $12K | ﹤0.01% |
4,936
-4
| -0.1% | -$16 |
2023 Q1
3 quarters
|
|
|
AIFU
6109
AIFU Inc
AIFU
$65.9M
| $12K | ﹤0.01% |
5
-2
| -29% | -$5.52K |
2023 Q3
1 quarter
|
|
6110
Innovator US Equity Power Buffer ETF August
PAUG
$1.04B
| $11.9K | ﹤0.01% |
356
-21
| -6% | -$670 |
2023 Q2
2 quarters
|
|
6111
Icahn Enterprises
IEP
$4.81B
| $11.8K | ﹤0.01% |
688
+94
| +16% | +$1.65K |
2015 Q1
35 quarters
|
|
6112
ProShares UltraPro Short S&P 500
SPXU
$427M
| $11.8K | ﹤0.01% |
69
-1,202
| -95% | -$258K |
2023 Q2
2 quarters
|
|
6113
CALL
Rivian
RIVN
$21.4B
| $11.7K | ﹤0.01% |
+500
| New | +$9.4K |
2023 Q4
0 quarters
|
|
6114
CXApp Inc Warrant
CXAIW
$623K
| – | – |
0
| – | – |
2021 Q1
11 quarters
|
|
6115
Aterian
ATER
$11M
| $11.7K | ﹤0.01% |
2,797
+11
| +0.4% | +$42 |
2020 Q3
13 quarters
|
|
|
DFSI
6116
Dimensional International Sustainability Core 1 ETF
DFSI
$1.15B
| $11.6K | ﹤0.01% |
362
-1,999
| -85% | -$59K |
2023 Q1
3 quarters
|
|
6117
Global X E-commerce ETF
EBIZ
$25.5M
| $11.6K | ﹤0.01% |
+546
| New | +$10.3K |
2023 Q4
0 quarters
|
|
|
FGB
6118
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
| $11.5K | ﹤0.01% |
3,210
+2,201
| +218% | +$7.24K |
2023 Q1
3 quarters
|
|
6119
First Trust New York Municipal High Income ETF
FMNY
$36.2M
| $11.4K | ﹤0.01% |
420
+304
| +262% | +$7.9K |
2023 Q3
1 quarter
|
|
|
PBLA
6120
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
| $11.4K | ﹤0.01% |
+623
| New | +$9.75K |
2023 Q4
0 quarters
|
|
6121
Nuveen ESG High Yield Corporate Bond ETF
NUHY
$111M
| $11.3K | ﹤0.01% |
536
-83
| -13% | -$1.68K |
2023 Q3
1 quarter
|
|
|
QVCGB
6122
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
| $11.3K | ﹤0.01% |
34
+17
| +100% | +$6.16K |
2023 Q2
2 quarters
|
|
|
DADA
6123
DELISTED
Dada Nexus
DADA
| $11.2K | ﹤0.01% |
3,373
-8,618,232
| -100% | -$31.8M |
2020 Q2
14 quarters
|
|
|
BIMI
6124
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
| $11.1K | ﹤0.01% |
5,164
-1
| -0% | -$2 |
2023 Q2
2 quarters
|
|
6125
United States 12 Month Oil Fund,
USL
$49.2M
| $11.1K | ﹤0.01% |
316
-246
| -44% | -$9.19K |
2020 Q1
15 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.